NEWS

Leukosight obtains grant from the Maryland Technology Development Corporation.

Dr. David M. Mosser, CEO of LeukoSight, Inc., presents recent findings at the Annual Meeting of the European League Against Rheumatism (EULAR) in Rome.

Dr. David M. Mosser, CEO of LeukoSight will give a Plenary Lecture at the Annual Meeting of the European Society for Biomaterials, in Dublin, IR  on September 8, 2011.

Dr. David M. Mosser, CEO of LeukoSight has been invited to present his latest findings at the 10th World Congress on Inflammation in Paris, France in June 2011.